Subscribe

Real Clinics. Real Patients. Real Oncology.

Home / Tags / RET

Home /

RET

RET

Home / Tags / RET

Home /

RET

Home / Tags / RET

Home /

News / RET

Recent Updates

Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC

New phase 3 data spotlight a major advance in RET-positive NSCLC. See how this landmark trial could innovate early-stage treatment.

June 1, 2026

Image without description (no attachment ID found)

RET

Image without description (no attachment ID found)
Recent Updates

Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC

June 1, 2026

Image without description (no attachment ID found)
Recent Updates

Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC

June 1, 2026

News & Insights

Image without description (no attachment ID found)
Recent Updates

Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC

June 1, 2026

Podcasts

No results were found

What are you
looking for?

POPULAR SEARCHES

Blood-Based Tests

Breast Cancer

Cancer Types

Cellular Therapies (e.g., CAR T)